NGISX
Price
$19.94
Change
-$0.16 (-0.80%)
Updated
Jul 13 closing price
Net Assets
1.64B
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

NGISX vs VSTSX

NGISX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
NGISX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NGISX is a Buy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. NGISX (1.64B). VSTSX pays higher dividends than NGISX: VSTSX (1.07) vs NGISX (0.77). NGISX was incepted earlier than VSTSX: NGISX (15 years) vs VSTSX (10 years). NGISX (0.61) is less costly to investors than VSTSX (0.01). NGISX is a more actively managed with annual turnover of: 13.78 vs. VSTSX (3.00). NGISX has a lower initial minimum investment than VSTSX: NGISX (50000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. NGISX (16.70). VSTSX return over 5 years is better than : 66.56 vs. NGISX (45.91).
NGISXVSTSXNGISX / VSTSX
Total Expense Ratio0.590.015,900%
Annual Report Gross Expense Ratio0.610.016,100%
Fund Existence15 years10 years-
Gain YTD10.67411.20595%
Front LoadN/AN/A-
Min. Initial Investment5000050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.64B2.3T0%
Annual Yield % from dividends0.771.0772%
Returns for 1 year16.7021.4878%
Returns for 3 years56.5767.0684%
Returns for 5 years45.9166.5669%
Returns for 10 years95.89239.5340%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I